Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 2
1994 1
1995 4
1996 6
1997 2
1998 4
1999 7
2000 1
2001 9
2002 7
2003 4
2004 8
2005 13
2006 9
2007 14
2008 13
2009 8
2010 9
2011 9
2012 7
2013 5
2014 11
2015 6
2016 10
2017 3
2018 5
2019 5
2020 7
2021 14
2022 6
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

193 results

Results by year

Filters applied: . Clear all
Page 1
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis.
Montalban X, Hauser SL, Kappos L, Arnold DL, Bar-Or A, Comi G, de Seze J, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Rammohan KW, Selmaj K, Traboulsee A, Sauter A, Masterman D, Fontoura P, Belachew S, Garren H, Mairon N, Chin P, Wolinsky JS; ORATORIO Clinical Investigators. Montalban X, et al. N Engl J Med. 2017 Jan 19;376(3):209-220. doi: 10.1056/NEJMoa1606468. Epub 2016 Dec 21. N Engl J Med. 2017. PMID: 28002688 Free article. Clinical Trial.
Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper).
Wiendl H, Gold R, Berger T, Derfuss T, Linker R, Mäurer M, Aktas O, Baum K, Berghoff M, Bittner S, Chan A, Czaplinski A, Deisenhammer F, Di Pauli F, Du Pasquier R, Enzinger C, Fertl E, Gass A, Gehring K, Gobbi C, Goebels N, Guger M, Haghikia A, Hartung HP, Heidenreich F, Hoffmann O, Kallmann B, Kleinschnitz C, Klotz L, Leussink VI, Leutmezer F, Limmroth V, Lünemann JD, Lutterotti A, Meuth SG, Meyding-Lamadé U, Platten M, Rieckmann P, Schmidt S, Tumani H, Weber F, Weber MS, Zettl UK, Ziemssen T, Zipp F; ‘Multiple Sclerosis Therapy Consensus Group’ (MSTCG). Wiendl H, et al. Among authors: limmroth v. Ther Adv Neurol Disord. 2021 Aug 18;14:17562864211039648. doi: 10.1177/17562864211039648. eCollection 2021. Ther Adv Neurol Disord. 2021. PMID: 34422112 Free PMC article. Review.
A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis.
Giovannoni G, Comi G, Cook S, Rammohan K, Rieckmann P, Soelberg Sørensen P, Vermersch P, Chang P, Hamlett A, Musch B, Greenberg SJ; CLARITY Study Group. Giovannoni G, et al. N Engl J Med. 2010 Feb 4;362(5):416-26. doi: 10.1056/NEJMoa0902533. Epub 2010 Jan 20. N Engl J Med. 2010. PMID: 20089960 Free article. Clinical Trial.
Analgesics.
Diener HC, Limmroth V. Diener HC, et al. Among authors: limmroth v. Curr Med Res Opin. 2001;17 Suppl 1:s13-6. doi: 10.1185/0300799039117014. Curr Med Res Opin. 2001. PMID: 12463271 Review.
The BETACONNECT™ system: MS therapy goes digital.
Limmroth V, Bartzokis I, Bonmann E, Kusel P, Schreiner T, Schürks M. Limmroth V, et al. Neurodegener Dis Manag. 2018 Dec;8(6):399-410. doi: 10.2217/nmt-2018-0030. Epub 2018 Oct 3. Neurodegener Dis Manag. 2018. PMID: 30278827 Free article. Review.
Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity.
Ostkamp P, Salmen A, Pignolet B, Görlich D, Andlauer TFM, Schulte-Mecklenbeck A, Gonzalez-Escamilla G, Bucciarelli F, Gennero I, Breuer J, Antony G, Schneider-Hohendorf T, Mykicki N, Bayas A, Then Bergh F, Bittner S, Hartung HP, Friese MA, Linker RA, Luessi F, Lehmann-Horn K, Mühlau M, Paul F, Stangel M, Tackenberg B, Tumani H, Warnke C, Weber F, Wildemann B, Zettl UK, Ziemann U, Müller-Myhsok B, Kümpfel T, Klotz L, Meuth SG, Zipp F, Hemmer B, Hohlfeld R, Brassat D, Gold R, Gross CC, Lukas C, Groppa S, Loser K, Wiendl H, Schwab N; German Competence Network Multiple Sclerosis (KKNMS) and the BIONAT Network. Ostkamp P, et al. Proc Natl Acad Sci U S A. 2021 Jan 5;118(1):e2018457118. doi: 10.1073/pnas.2018457118. Proc Natl Acad Sci U S A. 2021. PMID: 33376202 Free PMC article.
Medication-overuse headache.
Pageler L, Savidou I, Limmroth V. Pageler L, et al. Among authors: limmroth v. Curr Pain Headache Rep. 2005 Dec;9(6):430-5. doi: 10.1007/s11916-005-0023-6. Curr Pain Headache Rep. 2005. PMID: 16282044 Free article. Review.
Antimigraine drugs.
Diener HC, Kaube H, Limmroth V. Diener HC, et al. Among authors: limmroth v. J Neurol. 1999 Jul;246(7):515-9. doi: 10.1007/s004150050396. J Neurol. 1999. PMID: 10463349 Review.
[Migraine therapy].
Diener HC, Limmroth V. Diener HC, et al. Among authors: limmroth v. Internist (Berl). 2005 Oct;46(10):1087-95. doi: 10.1007/s00108-005-1459-9. Internist (Berl). 2005. PMID: 15995849 Review. German.
[Headache and migraine].
Diener HC, Slomke MA, Limmroth V. Diener HC, et al. Among authors: limmroth v. Nervenarzt. 2007 Sep;78 Suppl 1:7-13; quiz 14. doi: 10.1007/s00115-007-2332-y. Nervenarzt. 2007. PMID: 17687534 German.
193 results